Hi @ianwill, Imugene are up there with the best, they have 4-5 shots on goal with early results being positive.
Management have been involved in successful drug approvals so they know what is required, no drug gets to approval without some ups and downs and we know it can be a slow, drawn out process.
At times I would agree with the Lotto analogy, however given the outstanding pre-clinical data and the quality of management I am happy with my ticket.
Success can be measured in a myriad of ways, and any successful investor will tell you of the many failures they have had before they purchased the winning ticket.
All the best to you with your ticket.
DYOR opinion only
Ann: Imugene onCARlytics Doses First Patient in IV Combination, page-186
-
- There are more pages in this discussion • 26 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $364.4M | |||
| Open | High | Low | Value | Volume |
| 4.9¢ | 5.2¢ | 4.9¢ | $531.4K | 10.66M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 23 | 3429444 | 4.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.0¢ | 149299 | 2 |
View Market Depth
| Last trade - 16.10pm 18/10/2024 (20 minute delay) ? |
| IMU (ASX) Chart |